Your browser is no longer supported. Please, upgrade your browser.
Settings
ESRX Express Scripts Holding Company daily Stock Chart
ESRX [NASD]
Express Scripts Holding Company
IndexS&P 500 P/E26.86 EPS (ttm)3.05 Insider Own0.20% Shs Outstand675.73M Perf Week1.25%
Market Cap55.36B Forward P/E13.53 EPS next Y6.06 Insider Trans-7.25% Shs Float674.05M Perf Month-8.18%
Income2.21B PEG2.06 EPS next Q1.44 Inst Own98.30% Short Float9.94% Perf Quarter-5.32%
Sales102.44B P/S0.54 EPS this Y14.30% Inst Trans3.36% Short Ratio16.10 Perf Half Y-3.42%
Book/sh23.43 P/B3.50 EPS next Y10.05% ROA4.20% Target Price99.30 Perf Year11.55%
Cash/sh1.07 P/C76.79 EPS next 5Y13.02% ROE11.50% 52W Range68.06 - 94.61 Perf YTD-3.24%
Dividend- P/FCF13.16 EPS past 5Y11.20% ROI7.60% 52W High-12.50% Beta1.37
Dividend %- Quick Ratio0.50 Sales past 5Y32.50% Gross Margin8.30% 52W Low21.63% ATR2.71
Employees29500 Current Ratio0.60 Sales Q/Q1.40% Oper. Margin4.60% RSI (14)38.68 Volatility2.51% 3.16%
OptionableYes Debt/Eq1.06 EPS Q/Q31.30% Profit Margin2.20% Rel Volume0.55 Prev Close81.93
ShortableYes LT Debt/Eq0.92 EarningsJul 28 AMC Payout0.00% Avg Volume4.16M Price82.78
Recom2.30 SMA20-4.61% SMA50-7.03% SMA200-3.61% Volume1,798,229 Change1.04%
Jul-30-15Reiterated RBC Capital Mkts Outperform $87 → $96
Jul-16-15Initiated Mizuho Buy $98 → $101
Jun-18-15Initiated Oppenheimer Perform
Jun-01-15Downgrade Raymond James Outperform → Mkt Perform
May-20-15Initiated Robert W. Baird Neutral $94
Mar-10-15Reiterated RBC Capital Mkts Outperform $82 → $87
Feb-24-15Reiterated Mizuho Buy $94 → $98
Feb-24-15Reiterated Maxim Group Buy $90 → $109
Jan-28-15Downgrade FBR Capital Outperform → Mkt Perform
Jan-08-15Reiterated Mizuho Buy $82 → $94
Dec-16-14Reiterated Oppenheimer Outperform $82 → $88
Dec-15-14Reiterated UBS Buy $82 → $96
Dec-04-14Reiterated Deutsche Bank Hold $76 → $88
Dec-03-14Reiterated Barclays Overweight $83 → $94
Oct-30-14Reiterated RBC Capital Mkts Outperform $73 → $82
Jul-30-14Reiterated FBR Capital Outperform $79 → $74
Jul-28-14Reiterated UBS Buy $90 → $82
May-01-14Reiterated Maxim Group Buy $92 → $90
Apr-30-14Reiterated Mizuho Buy $86 → $82
Mar-06-14Reiterated Deutsche Bank Hold $75 → $79
Aug-28-15 12:45PM  Halftime Portfolio: Jon buys Seadrill
10:35AM  Amgen's PCSK9 Inhibitor, Repatha, Approved in the U.S.
06:00AM  Amgen approved for pricey new drug
Aug-27-15 10:07PM  The New Cholesterol Lowering Drugs Epitomize The Drug Pricing Battles at Forbes
06:43PM  FDA approves Amgen's cholesterol-lowering drug Repatha Reuters
Aug-26-15 08:48AM  Near-term stock swaps
Aug-24-15 05:54PM  LabCorp Reaching Past Doctor's Office To The Patient at Investor's Business Daily
Aug-20-15 05:54PM  Dividend cuts for big oil?
05:42PM  Cholesterol war heats up
Aug-18-15 07:32PM  Jeremy Grantham Reduces More Than 250 Stakes in Second Quarter
06:51PM  Why Target will be different than Wal-Mart: Analyst at CNBC
10:15AM  Target brings in Cathy Smith as CFO at bizjournals.com
Aug-17-15 05:09PM  Target Goes Outside for New CFO After Internal Promotion at The Wall Street Journal
03:02PM  Think Amazon's Bad? Here are 6 Companies with Worse Culture at TheStreet
09:01AM  Target promotes CFO Mulligan to COO
08:46AM  Executive changes at the top at Target
Aug-16-15 01:18PM  3 Charts That Show Healthcare Stocks Should Stay Hot for Years to Come at Motley Fool
Aug-14-15 07:08AM  Lilly CEO talks drug pricing pressure
Aug-13-15 11:34AM  Gilead Sciences: Why Hepatitis-C Sales Could Fall Short at Barrons.com
07:08AM  The 5 Least Inspiring CEOs in America at Motley Fool
Aug-12-15 10:40AM  The Next Great Dividend Stocks of the S&P 500 at Kiplinger
Aug-11-15 09:07AM  CVS Reports a Solid Quarter and Outlook in Pharmacy Services
04:16AM  Sellers target Express Scripts
Aug-10-15 05:05PM  CVS Healths Upbeat Outlook for 2Q15 and 2015
02:40PM  CVS, Express Scripts Pick Drugs to Restrict; Did Gilead's Sovalidi Make the Cut? at Barrons.com
12:39PM  Pharmacy benefit manager CVS urges rewrite for U.S. heart guidelines
10:11AM  Earnings Analysis: CVS Healths Performance in 2Q15
09:30AM  Zacks Investment Ideas feature highlights: INC Research, AMN Healthcare Services, Charles River Associates, Envision Healthcare and Express Scripts - Press Releases
Aug-06-15 11:53PM  Drug-Plan Managers Wield Potent Weapon at The Wall Street Journal
07:54PM  Drug-Plan Managers Wield 'Potent Weapon' at The Wall Street Journal
07:18AM  What Does the Social Media Crowd Think About Express Scripts (ESRX) Stock? - Tale of the Tape
Aug-05-15 05:37PM  CVS strips Viagra, other top drugs, from insurance coverage
Aug-04-15 12:06PM  Express Scripts Holding Co. Earnings Q2*, 2015
10:04AM  No More Viagra: CVS Drops Coverage of Erectile Dysfunction Drug at Bloomberg
09:07AM  Drivers That Impact CVSs Pharmacy Services Segment
Aug-01-15 01:04PM  EXPRESS SCRIPTS HOLDING CO. Financials
Jul-31-15 04:24PM  Express Scripts excludes 20 more drugs from 2016 coverage Reuters
Jul-29-15 11:12PM  How Express Scripts Makes Money at Investopedia
06:26PM  Express Scripts says costly new cholesterol drugs could 'wreak havoc' Reuters
05:40PM  DoD awards medical records contract to Cerner, Leidos & A...
04:30PM  Edited Transcript of ESRX earnings conference call or presentation 29-Jul-15 12:30pm GMT
03:42PM  Express Scripts (ESRX) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
12:24PM  Dow adds 100 points as Street awaits Fed statement; earnings eyed at CNBC
11:21AM  Express Scripts Holding Company Posts Solid Q2 Earnings at Motley Fool
11:15AM  Express Scripts says costly new cholesterol drugs could wreak havoc Reuters
09:35AM  Express Scripts (ESRX) Tops Q2 Earnings, Ups 2015 View - Analyst Blog
08:30AM  Express Scripts Holding Co Earnings Call scheduled for 8:30 am ET today
07:54AM  Early movers: HLT, ANTM, ETN, TWTR, GSK & more at CNBC
Jul-28-15 05:03PM  Express Scripts Raises Guidance as Earnings Top Views at The Wall Street Journal
04:43PM  Express Scripts tops 2Q profit forecasts
04:25PM  Express Scripts (ESRX) Stock Gains in After-Hours Trading on Earnings Beat at TheStreet
04:18PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
04:09PM  Express Scripts Announces 2nd Quarter Results; Increases 2015 Guidance Range PR Newswire
12:58PM  Top trades for the 2nd half: ESRX, MA & GILD
09:30AM  The Zacks Analyst Blog Highlights: Gilead Sciences, AbbVie, Merck, Achillion Pharmaceuticals and Express Scripts - Press Releases
07:07AM  Q2 2015 Express Scripts Holding Co Earnings Release - After Market Close
Jul-27-15 10:48AM  How does the role of Medicare/Medicaid affect the drugs sector in the U.S.? at Investopedia
Jul-24-15 05:17PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers
03:20PM  Will Express Scripts (ESRX) Miss Earnings Estimates in Q2? - Analyst Blog
Jul-23-15 03:57PM  Express Scripts Holding Company Earnings: What to Watch at Motley Fool
Jul-21-15 04:20PM  Can Bristol-Myers (BMY) Keep its Earnings Streak Alive? - Analyst Blog
Jul-18-15 12:40PM  Patients squeezed in Gilead, insurer showdown over costly hep C drugs at bizjournals.com
Jul-16-15 05:34AM  Coverage initiated on Express Scripts by Mizuho
Jul-15-15 08:02AM  3 Pharmacy Benefit Manager Stocks to Watch at Motley Fool
Jul-06-15 05:04PM  Express Scripts Holding Company Announces Second Quarter 2015 Earnings Conference Call GlobeNewswire
Jul-02-15 02:50PM  Express Scripts Reports Public Exchange Pharmacy Trends - Analyst Blog
Jul-01-15 04:00PM  Express Scripts: Healthier exchange enrollees aiding health plans at bizjournals.com
01:37PM  Best play for rest of 2015
01:33PM  Pisani: Sector trends intact
07:00AM  Express Scripts Provides First Look at 2015 Public Exchange Pharmacy Trends PR Newswire
12:01AM  Obamacare Customers Get Younger as Drug Costs Fall, Study Finds at Bloomberg
12:01AM  Obamacare Customers Get Younger as Drug Costs Fall, Study Finds
12:00AM  Birth Control Use Among Obamacare Patients Jumps 29 Percent at Forbes
Jun-30-15 03:33PM  The 10 Worst Companies To Work For
10:42AM  Listen to Employees When Evaluating Leadership - Not Just Earnings at Forbes
Jun-26-15 01:56PM  Markets sailing into the wind: Pro
12:59PM  Obamacare is Here to Stay: 3 ETFs to Buy - ETF News And Commentary
Jun-23-15 01:31PM  These stocks will move when the Supreme Court rules on Obamacare
10:48AM  Obamacare ruling, Taylor Swift's Apple saga, and Amazon still selling Confederate flag
Jun-22-15 06:15PM  UnitedHealth Group undisputed titan in space: Cramer
Jun-20-15 09:00AM  The 10 biggest health-care companies in the Fortune 500 at Fortune
Jun-19-15 12:48PM  Healthcare heats up in the summer
Jun-18-15 07:31PM  David Rolfe Adds to Most Valuable Stakes in His Portfolio
Jun-17-15 10:22AM  Economists predict shockwaves if Obamacare subsidies are nixed
Jun-16-15 12:04PM  10 Stock Picks from Top Fund Managers at Barrons.com
06:00AM  Jim Cramer's Top Takeaways: CVS, Target, Twitter, Express Scripts at TheStreet
Jun-15-15 08:18PM  Jim Cramer's 'Mad Money' Recap: Why Greece Pushed Rite Aid Lower at TheStreet
07:41PM  Cramer Remix: Twitter-get it together, or fail at CNBC
Jun-12-15 05:12PM  EXPRESS SCRIPTS HOLDING CO. Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure,
05:00PM  Express Scripts Elects Tim Wentworth to Board of Directors PR Newswire
Jun-11-15 06:25PM  ABC packs a big punch: Cramer
07:30AM  Healthcare ETFs: More Americans Are Visiting the Doctors Office
Jun-09-15 06:09PM  Regeneron Cholesterol Fighter Gets FDA Panel's Backing, 13-3
08:30AM  FDA weighs target population for Amgen cholesterol drug
Jun-08-15 03:50PM  Your guide to St. Louis public companies at bizjournals.com
Jun-04-15 02:17PM  Horizon Pharma Survives Through Transformation at Investor's Business Daily
Jun-02-15 04:45PM  Express Scripts to Present at the William Blair 35th Annual Growth Stock Conference PR Newswire
02:35PM  Whats so special about specialty drugs? at bizjournals.com
Jun-01-15 05:25PM  Biopharma price wars
01:56PM  Express Scripts (ESRX) Stock Falls on Analyst Downgrade at TheStreet
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company in the United States and Canada. The company operates through two segments, PBM and Other Business Operations. The company's PBM segment's services include clinical solutions to enhance health outcomes, such as adherence, case coordination, and personalized medicine; specialized pharmacy care; home delivery pharmacy; specialty pharmacy, including the distribution of fertility pharmaceuticals that require special handling or packaging; and retail network pharmacy administration. It also provides benefit design consultation; drug utilization review; drug formulary management; an array of Medicare, Medicaid, and health insurance marketplace; administration of a group purchasing organization; and consumer health and drug information services. In addition, the company distributes specialty pharmaceuticals and medical supplies to providers, clinics, and hospitals; and offers consulting services for pharmaceutical manufacturers to collect scientific evidence to guide the use of medicines, as well as case management approach to manage care by integrating pre-certification, case management, and discharge planning services for patients. It serves managed care organizations, health insurers, third-party administrators, employers, union-sponsored benefit plans, workers' compensation plans, government health programs, office-based oncologists, renal dialysis clinics, ambulatory surgery centers, primary care physicians, retina specialists, and others. The company was formerly known as Aristotle Holding, Inc. and changed its name to Express Scripts Holding Company in April 2012. Express Scripts Holding Company was founded in 1986 and is headquartered in St. Louis, Missouri.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Wimberly GarySr. VP & Ch. Information Off.Jun 09Sale87.141,644143,26020,885Jun 11 03:29 PM
Wimberly GarySr. VP & Ch. Information Off.Jun 01Option Exercise57.4946,0692,648,45868,598Jun 03 04:01 PM
Wimberly GarySr. VP & Ch. Information Off.Jun 01Sale86.1546,0693,968,84422,529Jun 03 04:01 PM
STERNBERG SEYMOURDirectorMay 27Option Exercise52.536,870360,88111,267May 29 04:02 PM
STERNBERG SEYMOURDirectorMay 27Sale90.236,870619,8594,397May 29 04:02 PM
MYERS WOODROW A JRDirectorMay 08Option Exercise54.0314,342774,92926,720May 12 04:14 PM
MYERS WOODROW A JRDirectorMay 08Sale85.3214,3421,223,64512,378May 12 04:14 PM
BENANAV GARY GDirectorMay 04Option Exercise30.8313,128404,73656,139May 06 04:01 PM
BENANAV GARY GDirectorMay 04Sale87.3910,000873,85046,139May 06 04:01 PM
Norton David ASVP, Specialty & Supply ChainMay 01Option Exercise49.507,000346,46523,280May 05 04:07 PM
Wade Sara ESr. VP, Ch. Human Res. Off.May 01Sale86.5312,0001,038,30028,599May 05 04:09 PM
Norton David ASVP, Specialty & Supply ChainMay 01Sale86.5312,0291,040,80911,251May 05 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Mar 02Sale84.392,674225,6598,291Mar 03 04:15 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 25Sale87.315,864511,98610,965Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Option Exercise47.6121,7391,034,99438,568Feb 26 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Feb 24Sale87.6221,7391,904,77016,829Feb 26 04:03 PM
Ebling Keith J.Exec. VP and General CounselDec 02Sale84.2510,000842,5000Dec 03 04:04 PM
Miller Steven BSr. VP & Chief Med. OfficerDec 01Sale83.574,896409,14416,521Dec 03 04:07 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Option Exercise47.6110,800514,18830,657Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 28Sale82.9610,800895,94619,857Dec 01 04:03 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Option Exercise47.6110,874517,71130,731Nov 25 04:38 PM
MAC MAHON THOMAS PDirectorNov 21Option Exercise35.8512,694455,01654,066Nov 25 04:40 PM
MAC MAHON THOMAS PDirectorNov 21Sale80.9312,6941,027,35141,372Nov 25 04:40 PM
Stettin Glen D.Sr. VP, Clin. Res. & New Sol.Nov 21Sale81.5010,874886,23119,857Nov 25 04:38 PM
PARKER JOHN ODirectorNov 17Option Exercise33.3025,822859,75365,503Nov 18 05:04 PM
PARKER JOHN ODirectorNov 17Sale78.7525,8222,033,43139,681Nov 18 05:04 PM
Breen Maura CDirectorNov 07Option Exercise30.8313,128404,73630,438Nov 10 04:16 PM
Breen Maura CDirectorNov 07Sale77.8013,1281,021,34517,310Nov 10 04:16 PM
IGNACZAK EDWARD BEVPSep 05Sale75.289,886744,21675,996Sep 09 05:01 PM